Oracle Prices $10B Share Sale at 11% Discount, Stock Sinks 14.6%
AiX — Free Expert Advisor
Trades XAUUSD on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. AiX is informational software — not investment advice. Past performance does not guarantee future results.
Oracle is set to price a $10 billion share sale at an 11% discount, according to reports, draining its entire capital-market funding allowance in a single week. The stock traded at $119.22 as of 01:14 UTC today, down 14.57%, inside a session range of $118.43 to $126.50. The parallel $10 billion bond sale is independent of the equity deal and runs across six tranches maturing between 2029 and 2046.
Context — Why Oracle's $10 Billion Equity Raise Matters Now
At its investor day last Wednesday, Oracle pledged to cap new capital-market funding for its fiscal 2027 to 2030 investment cycle at $20 billion, split evenly between equity and debt. Shares rallied 12% the next day on that restraint. Five days later, the company moved to raise the entire amount.
That reversal is the catalyst. The $10 billion equity sale and the $10 billion bond sale together consume the full funding cap, leaving no announced headroom for the rest of the cycle.
The timing also collides with a broader argument about who should pay for the AI buildout. Pershing Square's latest shareholder letter drew a line between the largest hyperscalers, which it said can largely fund spending from operating cash flow, and borrowers such as Oracle and the neoclouds that need outside capital. Oracle's raise sits on the outside-capital side of that line.
There is no comparable prior raise in the report, so the reference point is Oracle's own pledge from last week. The gap between that commitment and this week's action is what repriced the shares.
Data — What Oracle's Numbers Show
At Friday's closing price of about $131, the stock sale implied roughly 77 million new shares, lifting the count to about 3.1 billion and diluting existing holders by around 2.5%. Pricing at a discount requires more shares to raise the same $10 billion, so the dilution is slightly higher than that base case.
The report does not specify whether the 11% discount is measured against Friday's close or Monday's lower close. That distinction changes both the concession and the share count.
| Metric | Figure |
|---|---|
| Equity raise | $10 billion |
| Reported discount | 11% |
| Bond raise | $10 billion, six tranches, 2029-2046 |
| Combined funding | $20 billion |
| Implied new shares at $131 | ~77 million |
| Implied dilution | ~2.5% |
| Bond add to total debt | ~8% |
Oracle's total debt sits around $125 billion, so the notes add roughly 8%. The company reaffirmed fiscal 2027 guidance for at least $90 billion in revenue and $8.10 in adjusted earnings per share. It has lost nearly $65 billion in market value since Wednesday, with Monday's decline of 6% to 7% on top of the live 14.57% drop.
Analysis — What the Discount Signals for AI-Linked Borrowers
The equity discount is the concession investors demanded to absorb 77 million-plus new shares. A double-digit discount reads as a clearing level only if demand fills the book; it reads as weak demand if the deal prices wide and trades lower afterward.
The bond tranches are the sharper test. Where the 2029-to-2046 notes price relative to Oracle's existing debt will show what credit markets charge for AI-linked exposure. The bond sale would add about 8% to a $125 billion debt stack, so the marginal spread matters more than the headline size.
The second-order effect lands on the neoclouds and any AI-linked issuer that lacks a hyperscaler's operating cash flow. If Oracle pays up in both equity and credit, that sets a higher clearing price for the next borrower in line.
The counter-argument: Oracle reaffirmed fiscal 2027 revenue of at least $90 billion and adjusted EPS of $8.10, so the raise funds a guided plan rather than a shortfall. Pershing Square's framing cuts the other way too — it argues the hyperscalers should not be lumped in with Oracle, which means capital could rotate toward the self-funding names.
Positioning is the tell. Existing holders are absorbing dilution, while buyers of the new shares and the six bond tranches set the price. Morgan Stanley and Goldman Sachs are among the bookrunners on the stock sale.
Outlook — What to Watch After Oracle's $20 Billion Raise
Final pricing on both offerings is the first catalyst. The equity clearing price resolves whether 11% was a concession or a shortfall, and the bond spread against Oracle's existing debt resolves the credit question.
Watch $118.43, the low of today's range, as the level the market has already tested. A close back above $126.50, the top of the range, would mark the supply overhang as cleared. Neither level is a forecast, only the boundary the session has drawn.
Proceeds are earmarked for general corporate purposes, which can include capital expenditure, debt repayment, acquisitions, dividends and share buybacks. How Oracle deploys the $20 billion, and whether it returns to the market before fiscal 2030, sets the next repricing.
The company did not disclose the final terms of either offering.
Frequently Asked Questions
What does Oracle's 11% discount mean for existing shareholders?
A discount means Oracle issues more shares than the roughly 77 million implied by Friday's close of about $131, so dilution runs slightly above the 2.5% base case. Existing holders own a smaller slice of the same company. The discount is the price of getting $10 billion in the door without a longer marketing period, and it transfers value from current owners to the buyers of the new stock.
Why is Oracle raising debt and equity at the same time?
The two deals are independent, but together they hit the $20 billion cap Oracle set at its investor day for the fiscal 2027 to 2030 cycle, split evenly between the two. Raising both at once removes the overhang in a single step rather than leaving the market guessing about the next tap. The bond sale adds about 8% to Oracle's roughly $125 billion of total debt.
How does the Oracle raise affect other AI infrastructure borrowers?
Oracle now sits on the outside-capital side of the divide Pershing Square described, separate from hyperscalers it said can largely self-fund. If Oracle pays a double-digit equity discount and a wide bond spread, that becomes the reference price for neoclouds and other AI-linked issuers. Credit markets would then charge more for the same buildout at companies without Oracle's guided revenue base.
Bottom Line
Oracle is paying an 11% equity discount and adding 8% to its debt to fund an AI buildout it pledged to cap at $20 billion.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Trade XAUUSD on autopilot — free Expert Advisor
AiX is our free MetaTrader 5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. XAUUSD breakout engine.
PartnerTrade 800+ global stocks & ETFs
Start TradingSponsored
Ready to trade the markets?
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.